In August 2025, Adia Med announced its entry into the USD 1.9 billion glutathione market through the launch of innovative IV glutathione therapies and Glutaryl Transdermal Glutathione Spray
MET-097s promising Phase 1 results suggest that it could address several unmet needs in this space, particularly by offering: Once-Monthly Dosing: Unlike many other GLP-1 receptor agonists that require weekly or even daily administration, MET-097s extended half-life could enable monthly or less frequent dosing, significantly reducing the burden of frequent injections on patients
The PlexusDx Difference: Science, Empathy, Transparency PlexusDx's brand personality is built on being empathetic, innovative, trustworthy, supportive, results-oriented, and personalized
Semaglutide has no specific dietary guidelines
Ingredients Key Ingredients Glutathione, Vitamin E
This prevents backflow and ensures the full dose is deposited in the subcutaneous tissue